SCHEMBL22673933

SCHEMBL22673933

CCOC(=O)c1ccc(C(=O)C(OC(=O)CC2CCN(C(=O)OC(C)(C)C)CC2)C(=O)OCC)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ GPR119 Q8TDV5 10/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ ATM Q13315 1/20 0.43
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ITGB3 P05106 1/20 0.41
▸ ITGA2B P08514 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22673922 0.87 KMT2A (0.47) NPSR1MAPTGPR119ATMKMT2A
SCHEMBL22673718 0.81 HPGD (0.48) MAPTKMT2AMEN1ALDH1A1LMNA
SCHEMBL6705316 0.79 L3MBTL1 (0.51) NPSR1MAPTGPR119KDM4EPKM
SCHEMBL22673801 0.78 MEN1 (0.53) NPSR1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL22674061 0.78 MEN1 (0.50) NPSR1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL22674058 0.78 MEN1 (0.50) NPSR1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL22673848 0.77 MEN1 (0.49) NPSR1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL22673925 0.77 ATM (0.40) NPSR1MAPTGPR119ATMKMT2A
SCHEMBL785988 0.77 HPGD (0.48) GPR119KDM4EPKMKMT2AMEN1
SCHEMBL8040438 0.77 NAMPT (0.54) NPSR1MAPTGPR119KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291516-B2 Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors HENAN ZHIWEI BIOMEDICINE CO., LTD. (CN) 2025-05-06 — — US disclosed
EP-3966204-B1 SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS HENAN ZHIWEI BIOMEDICINE CO LTD (CN) 2024-11-27 — — EP disclosed
CN-111909133-B Substituted 1-amino-1H-imidazole-5-carboxamides as inhibitors of brunauer tyrosine kinase 河南知微生物医药有限公司 2023-07-14 — — CN disclosed
US-20220259181-A1 SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS HENAN ZHIWEI BIOMEDICINE CO., LTD. (CN) 2022-08-18 — — US disclosed
WO-2020228637-A1 SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS HENAN NORMAL UNIVERSITY (CN) 2020-11-19 — — WO disclosed
CN-111909133-A Substituted 1-amino-1H-imidazole-5-carboxamides as brunauer tyrosine kinase inhibitors 河南师范大学 2020-11-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220259181-A1 SUBSTITUTED 1-AMINO-1H-IMIDAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE INHIBITORS BTK, SYK, TYK2 NPSR1 3697/4885MAPT 812/4885GPR119 2721/4885
US-12291516-B2 Substituted 1-amino-1H-imidazole-5-carboxamide as Bruton's tyrosine kinase inhibitors BTK, SYK, TYK2 NPSR1 3697/4885MAPT 812/4885GPR119 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback